Ocugen Inc (OCGN) |
|
0.623 0.025 (4.2%)
|
08-13 16:00 |
|
Open: |
0.6465 |
Pre. Close: |
0.5979 |
|
High:
|
0.648 |
Low:
|
0.58 |
|
Volume:
|
18,520,768 |
Market Cap:
|
84M |
|
|
|
|
Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases. Its pipeline includes OCU400 and OCU410 for the treatment of inherited retinal disorders; OCU200 for the treatment of wet-AMD, DME, and diabetic retinopathy; OCU100 for retinitis pigmentosa; and OCU300, which is in Phase III clinical trial for the treatment of ocular graft versus host diseases. The company has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing. Ocugen, Inc. is based in Malvern, Pennsylvania. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.65 - 0.654 |
0.654 - 0.657 |
|
Low:
|
0.573 - 0.576 |
0.576 - 0.579 |
|
Close:
|
0.615 - 0.62 |
0.62 - 0.625 |
|
Technical analysis |
as of: 2020-08-13 4:36:57 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.12 One year: 1.31 |
| Support: |
Support1: 0.48 Support2: 0.19 |
| Resistance: |
Resistance1: 0.96 Resistance2: 1.12 |
| Pivot: |
0.56 |
| Moving Average: |
MA(5): 0.62 MA(20): 0.50
MA(100): 0.33 MA(250): 2.09  |
| MACD: |
MACD(12,26): 0.08 Signal(9): 0.08 |
| Stochastic oscillator: |
%K(14,3): 48.23 %D(3): 51.15 |
| RSI: |
RSI(14): 61.42 |
| 52-week: |
High: 17.40 Low: 0.17 Change(%): -94.4 |
| Average Vol(K): |
3-Month: 3631179 10-Days: 3253548 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.OCGN has closed below upper band by 32.8%. Bollinger Bands are 87.5% wider than normal. The large width of the bands suggest high volatility as compared to OCGN's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 14 Aug 2020
Ocugen Provides Business Update and Second Quarter 2020 Financial Results - GlobeNewswire
Thu, 13 Aug 2020
Fresh Data-Based Insight On Ocugen, Inc. (OCGN) - Stocks Register
Thu, 13 Aug 2020
Renewed Optimism is Surrounding Ocugen Inc. (NASDAQ:OCGN) - The Oracle Dispatch
Wed, 12 Aug 2020
A New Orphan Drug Designation Gives Hope to Ocugen Stock - InvestorPlace
Wed, 12 Aug 2020
Ocugen Investors Are Missing the Obvious Signs of Failure - Investorplace.com
Wed, 12 Aug 2020
Why Ocugen, Inc. (OCGN) Is 'Ahead Of Itself ' - The News Heater
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGS |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
135 |
| Shares Float (M) |
61 |
|
% Held by Insiders
|
8.15 |
|
% Held by Institutions
|
11.98 |
|
Shares Short (K)
|
325 |
|
Shares Short P. Month (K)
|
311 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-119.2 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.098 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-19 |
|
Levered Free Cash Flow (M)
|
-23 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
-4.45 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
